BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Akhtar R, Chandel S, Sarotra P, Medhi B. Current status of pharmacological treatment of colorectal cancer. World J Gastrointest Oncol 2014; 6(6): 177-183 [PMID: 24936228 DOI: 10.4251/wjgo.v6.i6.177]
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/177.htm
Number Citing Articles
1
Achim Buck, Susanne Halbritter, Christoph Späth, Annette Feuchtinger, Michaela Aichler, Horst Zitzelsberger, Klaus-Peter Janssen, Axel Walch. Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSIAnalytical and Bioanalytical Chemistry 2015; 407(8): 2107 doi: 10.1007/s00216-014-8237-2
2
Sumit Basu, Min Zeng, Taijun Yin, Song Gao, Ming Hu. Development and validation of an UPLC–MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in ratsJournal of Chromatography B 2016; : 34 doi: 10.1016/j.jchromb.2016.02.012
3
Luca Falzone, Letizia Scola, Antonino Zanghì, Antonio Biondi, Antonio Di Cataldo, Massimo Libra, Saverio Candido. Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor developmentAging 2018; 10(5): 1000 doi: 10.18632/aging.101444
4
T.-W. Chien, Y. Chang, K.-S. Wen, Y.-H. Uen. Using graphical representations to enhance the quality-of-care for colorectal cancer patientsEuropean Journal of Cancer Care 2018; 27(1): e12591 doi: 10.1111/ecc.12591
5
Al B. Benson, Igor Kiss, John Bridgewater, Ferry A.L.M. Eskens, Carolyn Sasse, Sandra Vossen, Jihong Chen, Chip Van Sant, Howard A. Ball, Anne Keating, Andrew Krivoshik. BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal CancerClinical Cancer Research 2016; 22(20): 5058 doi: 10.1158/1078-0432.CCR-15-3117
6
Maria Rita Milone, Biagio Pucci, Tommaso Colangelo, Rita Lombardi, Federica Iannelli, Vittorio Colantuoni, Lina Sabatino, Alfredo Budillon. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotypeMolecular Oncology 2016; 10(8): 1344 doi: 10.1016/j.molonc.2016.07.006
7
Sekar Jinendiran, Hans-Uwe Dahms, B.S. Dileep Kumar, Vinoth Kumar Ponnusamy, Natesan Sivakumar. Diapolycopenedioic-acid-diglucosyl ester and keto-myxocoxanthin glucoside ester: Novel carotenoids derived from Exiguobacterium acetylicum S01 and evaluation of their anticancer and anti-inflammatory activitiesBioorganic Chemistry 2020; 103: 104149 doi: 10.1016/j.bioorg.2020.104149
8
Rita Seeböck, Nicole Golob-Schwarzl, Stefanie Krassnig. Mechanisms of Molecular Carcinogenesis – Volume 12017; : 77 doi: 10.1007/978-3-319-53659-0_5
9
Muhammed A. Bakhrebah, Mohammad Nasrullah, Wesam H. Abdulaal, Mohammed A. Hassan, Halima Siddiqui, Huda A. Al Doghaither, Ulfat M. Omar, Nawal Helmi, Mohannad M. Fallatah, Ayat B. Al-Ghafari, Mohammad Imran Khan, Hani Choudhry. High Expression of Pd-1 in Circulating Cells of Patients With Advanced Colorectal Cancer Receiving Adjuvant TherapyTechnology in Cancer Research & Treatment 2020; 19: 153303382096944 doi: 10.1177/1533033820969446
10
Sarah Theiner, Christoph Kornauth, Hristo P. Varbanov, Markus Galanski, Sushilla Van Schoonhoven, Petra Heffeter, Walter Berger, Alexander E. Egger, Bernhard K. Keppler. Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(iv)-based anticancer agentsMetallomics 2015; 7(8): 1256 doi: 10.1039/C5MT00028A
11
Xin Wang, Jian Wang, Jingjing Wu. Emerging roles for HMGA2 in colorectal cancerTranslational Oncology 2021; 14(1): 100894 doi: 10.1016/j.tranon.2020.100894
12
Bashir A. Yousef, Hozeifa M. Hassan, Muhanad Elhafiz, Luyong Zhang, Zhenzhou Jiang. Synergistic anti-cancer effect of pristimerin and docetaxel on human colorectal HCT-116 cellsSynergy 2020; 11: 100068 doi: 10.1016/j.synres.2020.100068
13
Wentian Wang, Lu Zhang, Lorraine Morlock, Noelle S. Williams, Jerry W. Shay, Jef K. De Brabander. Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)Journal of Medicinal Chemistry 2019; 62(10): 5217 doi: 10.1021/acs.jmedchem.9b00532
14
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and futurePharmacology & Therapeutics 2020; 206: 107447 doi: 10.1016/j.pharmthera.2019.107447
15
Rosane Borges Dias, Ludmila de Faro Valverde, Clarissa Araújo Gurgel Rocha, Daniel Pereira Bezerra. Bioactive Essential Oils and Cancer2015; : 1 doi: 10.1007/978-3-319-19144-7_1
16
Hadar Goldvaser, Ofer Purim, Yulia Kundel, Daniel Shepshelovich, Tzippy Shochat, Lital Shemesh-Bar, Aaron Sulkes, Baruch Brenner. Colorectal cancer in young patients: is it a distinct clinical entity?International Journal of Clinical Oncology 2016; 21(4): 684 doi: 10.1007/s10147-015-0935-z
17
Mona S Abdellateif, Salem E Salem, Doaa M Badr, Sabry Shaarawy, Marwa M Hussein, Abdel-Rahman Zekri, Mariam A Fouad. The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer PatientsJournal of Inflammation Research 2020; : 1245 doi: 10.2147/JIR.S283069
18
Valérie Vinette, Morgane Placet, Guillaume Arguin, Fernand-Pierre Gendron, Hendrik W. van Veen. Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5’-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic DrugsPLOS ONE 2015; 10(8): e0136080 doi: 10.1371/journal.pone.0136080
19
Małgorzata Milczarek, Anna Pogorzelska, Katarzyna Wiktorska. Synergistic Interaction between 5-FU and an Analog of Sulforaphane—2-Oxohexyl Isothiocyanate—In an In Vitro Colon Cancer ModelMolecules 2021; 26(10): 3019 doi: 10.3390/molecules26103019